VINATIORGA - Vinati Organics
📢 Recent Corporate Announcements
Vinati Organics reported a consolidated net profit of ₹100.83 crore for Q3 FY26, representing a 7.6% increase compared to ₹93.70 crore in the same quarter last year. Revenue from operations remained relatively stagnant at ₹530.78 crore, showing a marginal 1.7% YoY growth but a 3.5% sequential decline from Q2. For the nine-month period ended December 2025, PAT grew by 13.3% to ₹319.89 crore, while revenue growth was muted at 1.4%. The board also approved revisions to several corporate policies, including the Dividend Distribution and Related Party Transactions policies.
- Consolidated Revenue for Q3 FY26 stood at ₹530.78 Cr, up 1.7% YoY but down 3.5% QoQ.
- Net Profit (PAT) for the quarter reached ₹100.83 Cr, a 7.6% increase YoY but a 12.2% drop from the previous quarter.
- 9M FY26 PAT increased to ₹319.89 Cr from ₹282.21 Cr in the previous year period.
- Earnings Per Share (EPS) for Q3 FY26 was ₹9.73 compared to ₹9.04 in Q3 FY25.
- Board approved revisions to the Dividend Distribution Policy and Code of Conduct for Insider Trading.
Vinati Organics reported a modest year-on-year growth for Q3 FY26, with consolidated revenue increasing 1.7% to ₹530.78 crore. Profit After Tax (PAT) grew by 7.6% YoY to ₹100.83 crore, although it witnessed a sequential decline of 12.2% from ₹114.88 crore in Q2 FY26. For the nine-month period, the company showed stronger performance with PAT rising to ₹319.89 crore from ₹282.21 crore. Additionally, the board approved revisions to several key governance policies, including the Dividend Distribution Policy.
- Consolidated Revenue from Operations grew 1.7% YoY to ₹530.78 crore in Q3 FY26.
- Consolidated Net Profit (PAT) increased 7.6% YoY to ₹100.83 crore, but declined 12.2% on a sequential (QoQ) basis.
- Nine-month consolidated PAT for FY26 reached ₹319.89 crore, up from ₹282.21 crore in the previous year.
- Basic Earnings Per Share (EPS) for the quarter stood at ₹9.73 compared to ₹9.04 in Q3 FY25.
- The Board approved revisions to the Dividend Distribution Policy and Related Party Transactions Policy.
Vinati Organics Limited has announced an additional investment of ₹31.19 Crore in its wholly-owned subsidiary, Veeral Organics Private Limited (VOPL). The company subscribed to 3,11,90,000 equity shares at a face value of ₹10 each through a rights issue. VOPL is engaged in manufacturing organic fine specialty chemicals, which is directly aligned with Vinati Organics' core business. This capital infusion is expected to support the subsidiary's growth and manufacturing capabilities.
- Additional investment of ₹31.19 Crore in wholly-owned subsidiary Veeral Organics
- Subscription to 3,11,90,000 equity shares at par value of ₹10 each
- Veeral Organics reported a turnover of ₹10.55 Crore
- Maintains 100% shareholding and control in the specialty chemicals entity
Vinati Organics Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by MUFG Intime India Pvt. Ltd., confirms that all share certificates received for dematerialization during the quarter ended December 31, 2025, were processed correctly. It verifies that physical certificates were mutilated and cancelled, and the names of depositories were updated in the register of members within the prescribed timelines. This is a standard administrative filing with no impact on the company's financial or operational standing.
- Compliance certificate submitted for the quarter ended December 31, 2025
- Issued by Registrar and Transfer Agent MUFG Intime India Private Limited
- Confirms dematerialization requests were accepted or rejected within mandated timelines
- Verification and cancellation of physical certificates completed as per SEBI norms
- Confirms that securities are listed on the stock exchanges where earlier securities were listed
Vinati Organics Limited has announced the closure of its trading window for all designated persons starting January 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the company's Q3 and nine-month financial results for the period ending December 31, 2025. The trading window will remain closed until 48 hours after the financial results are officially declared. The specific date for the board meeting to approve these results will be shared by the company in a separate notification.
- Trading window closure begins on January 1, 2026, for all designated and connected persons.
- Closure is mandatory for the consideration of unaudited financial results for the quarter and nine months ending December 31, 2025.
- The window will reopen 48 hours after the public announcement of the financial results.
- The date for the Board Meeting to approve the results is yet to be announced.
Financial Performance
Revenue Growth by Segment
The ATBS segment achieved 30% YoY growth in FY25, driven by volume expansion. The Butyl Phenols segment grew 26% YoY. Overall consolidated net income grew 18% from INR 1,939 Cr in FY24 to INR 2,292 Cr in FY25. Segment revenue contribution is: ATBS (35%), IBB (11%), IB/HP-MTBE (15%), Butyl Phenols (15%), and Antioxidants (10%).
Geographic Revenue Split
Not disclosed in available documents, though the company maintains a global market position with a well-diversified business across various geographies.
Profitability Margins
Standalone Operating Profit Margin improved to 23.94% in FY25 from 22.49% in FY24. Net Profit Margin rose to 18.11% from 16.68%. Long-term sustainable EBITDA margins for the specialty chemical B2B business are guided at 26-27%.
EBITDA Margin
Consolidated EBITDA rose 23% YoY to INR 625 Cr in FY25 from INR 509 Cr. Q4 FY25 EBITDA was INR 187 Cr, representing a 25% increase over Q3 FY25.
Capital Expenditure
Vinati allocated INR 391 Cr towards capital expenditure in FY25. Total ongoing capex is approximately INR 580 Cr, including INR 300 Cr for ATBS capacity expansion and INR 280 Cr in the subsidiary Veeral Organics Private Limited (VOPL).
Credit Rating & Borrowing
CareEdge Ratings assigned a Stable outlook. The company maintains a robust financial profile with an Interest Coverage Ratio of 1055.29x in FY25, up from 120.10x in FY24, indicating negligible borrowing costs relative to earnings.
Operational Drivers
Raw Materials
Key raw materials include crude derivatives such as Toluene, Propylene, Acrylonitrile, and Methyl Tert Butyl Ether (MTBE).
Import Sources
Not disclosed in available documents, though materials are linked to global petrochemical supply chains.
Capacity Expansion
Expanding ATBS capacity with a INR 300 Cr investment. VOPL is setting up capacity for MEHQ, Guaiacol, and Iso Amylene derivatives with a INR 500 Cr total project cost, of which INR 250 Cr is completed. VOPL expects 20% capacity utilization in FY26.
Raw Material Costs
Raw material costs are susceptible to crude price volatility; however, the company manages this through a lag-based price pass-through mechanism to customers to protect gross margins.
Manufacturing Efficiency
Inventory turnover ratio improved by 21.6% to 7.75x in FY25 from 6.37x in FY24, reflecting higher operational throughput.
Strategic Growth
Expected Growth Rate
20%
Growth Strategy
Growth will be achieved through a 20% top-line CAGR over the next 3 years by expanding ATBS volumes (30% growth in FY25), ramping up the Antioxidant business to 15-20% of total revenue, and commissioning new products like MEHQ and Guaiacol at VOPL, which is expected to contribute INR 100 Cr in FY26.
Products & Services
Specialty chemicals including ATBS (Acrylamido Tertiary Butyl Sulfonic Acid), IBB (Isobutyl Benzene), Butyl Phenols, Antioxidants (AO), MEHQ, Guaiacol, and Iso Amylene derivatives.
Brand Portfolio
Vinati Organics Limited (VOL), Veeral Organics Private Limited (VOPL).
New Products/Services
Commercial production of MEHQ has commenced; Anisole backward integration is slated for Q1 FY26. VOPL is expected to generate INR 100 Cr in new revenue in FY26.
Market Expansion
Targeting increased application of ATBS in the oil and gas sector (expected to reach 40-45% of segment demand) and scaling the Antioxidant portfolio globally.
Market Share & Ranking
Global leader in ATBS with a steady market share of 60-65%.
Strategic Alliances
Veeral Organics Private Limited is a 100% wholly-owned subsidiary; the company invested INR 38.45 Cr in VOPL equity during FY25.
External Factors
Industry Trends
The specialty chemicals industry is growing at a double-digit rate with a shift toward sustainable, zero-discharge manufacturing. Vinati is positioning itself through backward integration to become the lowest-cost producer in its segments.
Competitive Landscape
Vinati operates in a niche market with high entry barriers; key competition exists in the newer Antioxidant and Butyl Phenol segments from other global specialty chemical manufacturers.
Competitive Moat
Sustainable moat derived from a 60%+ global market share in ATBS, proprietary and complex manufacturing processes that act as entry barriers, and cost leadership through integrated operations.
Macro Economic Sensitivity
High sensitivity to global crude oil prices and GDP growth, which dictates demand for industrial specialty chemicals.
Consumer Behavior
Increasing demand for high-performance polymers in oil and gas applications is shifting the ATBS end-use profile.
Geopolitical Risks
Geopolitical tensions pose risks to the global supply chain and the cost of imported chemical feedstocks.
Regulatory & Governance
Industry Regulations
Operations are subject to stringent environmental, health, and safety (EHS) regulations and pollution control norms applicable to the chemical industry.
Environmental Compliance
The company operates backward-integrated manufacturing with zero-discharge processes. CSR expenditure for the period was INR 9.47 Cr.
Legal Contingencies
The Secretarial Audit for FY25 reported no major specific events or legal actions having a major bearing on the company's affairs.
Risk Analysis
Key Uncertainties
Execution risks associated with the INR 580 Cr ongoing capex and the successful market ramp-up of new products from the VOPL subsidiary.
Geographic Concentration Risk
Not disclosed in available documents, though the company has a broad global export footprint.
Third Party Dependencies
Dependency on third-party suppliers for crude-based raw materials is being mitigated by backward integration into Anisole.
Technology Obsolescence Risk
Low risk due to the specialized nature of the chemical processes and continuous investment in R&D and process innovation.
Credit & Counterparty Risk
Receivables quality is stable with a turnover ratio of 4.00x, indicating healthy collections from its global clientele.